Evidence map›Paper›PMID 41439850›Full record

ArticleEpidemiologia (Basel, Switzerland)2025

Spina Bifida Incidence Trends: A Comparative Study of Puerto Rico and the United States.

Eric Pérez-Pérez, Esteban Rivera-Rivera, Natasha Frontera, Alejandro Cedeño-Moran, Camelia Carvajal-Matta, Jeremy González, Aixa de Jesús-Espinosa, Iván Sosa-González, Miguel Mayol Del Valle

Abstract read
In one paragraph

Article in Epidemiologia (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Eric Pérez-PérezSchool of Medicine, University of Puerto Rico, San Juan 00931, Puerto Rico.
Esteban Rivera-RiveraSection of Neurosurgery, Department of Surgery, School of Medicine, University of Puerto Rico, San Juan 00931, Puerto Rico.ORCID 0000-0001-7642-0819
Natasha FronteraDepartment of Surgery, School of Medicine, University of Puerto Rico, San Juan 00931, Puerto Rico.
Alejandro Cedeño-MoranSchool of Medicine, University of Puerto Rico, San Juan 00931, Puerto Rico.
Camelia Carvajal-MattaSchool of Medicine, University of Puerto Rico, San Juan 00931, Puerto Rico.
Jeremy GonzálezSchool of Medicine, University of Puerto Rico, San Juan 00931, Puerto Rico.
Aixa de Jesús-EspinosaSection of Neurosurgery, Department of Surgery, School of Medicine, University of Puerto Rico, San Juan 00931, Puerto Rico.ORCID 0000-0002-4028-2204
Iván Sosa-GonzálezSection of Neurosurgery, Department of Surgery, School of Medicine, University of Puerto Rico, San Juan 00931, Puerto Rico.
Miguel Mayol Del ValleSection of Neurosurgery, Department of Surgery, School of Medicine, University of Puerto Rico, San Juan 00931, Puerto Rico.ORCID 0000-0002-3269-3994

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesNeural tube defects such as myelomeningocele (MMC) remain a significant public health concern despite prevention efforts. Public health measures have reduced the global MMC incidence, but socioeconomic disparities may limit their impact. Puerto Rico (PR) is a United States (US) territory; however, its socioeconomic landscape is vastly different, which may contribute to differences in MMC incidence. In this study, we aimed to compare the differences in MMC incidence and annual variability between PR and the US. MATERIALS AND

methodsData on MMC incidence for the US was obtained from the Centers for Disease Control's National Vital Statistics Reports, and data for PR from the Puerto Rico Birth Defects Surveillance and Prevention System. Annual percentage change (APC) was used to evaluate year-to-year variation, and multiple linear regression analysis was applied to compare incidence rates.

resultsThe mean annual MMC incidence in 1996-2020 was 4.88 per 10,000 live births in PR (SD = 1.86), and 1.78 (SD = 0.35) in the US, with an estimated mean difference of 3.11 (

conclusionsDespite folic acid fortification and public health interventions, MMC incidence in PR remains higher and more variable. These findings underscore the need for improved disease reporting and targeted, region-specific preventive strategies.

Indexed as

congenital defectsfolic acidmyelomeningoceleneural tube defectsspina bifida

Identifiers

PMID41439850
PMCPMC12732084

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.